![Tassos Gianakakos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tassos Gianakakos
Nessuna posizione attualmente
Patrimonio netto: 198 M $ in data 31/08/2026
Profilo
Attualmente, Anastasios E. Gianakakos ricopre la posizione di amministratore delegato di MyoKardia, Inc. È anche nel consiglio di amministrazione di LianBio. In passato il signor Gianakakos è stato presidente e vicepresidente senior dello sviluppo aziendale presso Codexis, Inc., ingegnere di processo presso Merck & Co., Inc., direttore dello sviluppo aziendale presso Maxygen, Inc. e amministratore delegato e vicepresidente senior presso MAP Pharmaceuticals LLC. Ha conseguito una laurea al Massachusetts Institute of Technology, una laurea alla Northwestern University e un MBA alla Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
10,49% | 30/06/2026 | 9.806.633 ( 10,49% ) | 198 M $ | 31/08/2026 |
LIANBIO 0,35% | 15/02/2024 | 363.253 ( 0,35% ) | 18 072 $ | 31/08/2026 |
Posizioni attive di Tassos Gianakakos
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Tassos Gianakakos
| Società | Posizione | Fine |
|---|---|---|
Prolaio, Inc.
 Prolaio, Inc. BiotechnologyHealth Technology Operates as a patient-centered clinical intelligence company dedicated to cardiology research and care ecosystem | Amministratore Delegato | 01/02/2025 |
| LIANMEDICAL | Direttore/Membro del Consiglio | 01/03/2024 |
| MYOKARDIA, INC. | Amministratore Delegato | 01/11/2020 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Corporate Officer/Principal | 01/03/2013 |
| MERCK & CO., INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 |
Formazione di Tassos Gianakakos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Prolaio, Inc.
Prolaio, Inc. BiotechnologyHealth Technology Operates as a patient-centered clinical intelligence company dedicated to cardiology research and care ecosystem | Health Technology |
